SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Averion International Corp. (OTC BB: AVRO), an international clinical research organization (CRO) specializing in oncology, cardiovascular diseases and medical devices, today announced financial results for the three months ended March 31, 2008.
